ITMI950529A0 - Composizioni farmaceutiche e procedimento per la loro preparazione - Google Patents

Composizioni farmaceutiche e procedimento per la loro preparazione

Info

Publication number
ITMI950529A0
ITMI950529A0 ITMI950529A ITMI950529A ITMI950529A0 IT MI950529 A0 ITMI950529 A0 IT MI950529A0 IT MI950529 A ITMI950529 A IT MI950529A IT MI950529 A ITMI950529 A IT MI950529A IT MI950529 A0 ITMI950529 A0 IT MI950529A0
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ITMI950529A
Other languages
English (en)
Inventor
Christopher Buchan Jones
John Henry Platt
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48793621&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI950529(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ITMI950529A0 publication Critical patent/ITMI950529A0/it
Publication of ITMI950529A1 publication Critical patent/ITMI950529A1/it
Application granted granted Critical
Publication of IT1281193B1 publication Critical patent/IT1281193B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IT95MI000529A 1994-03-22 1995-03-17 Composizioni farmaceutiche contenenti 2,6 diisopropilfenolo (propofol) e metodo per la loro preparazione IT1281193B1 (it)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
GB9405593A GB9405593D0 (en) 1994-03-22 1994-03-22 Pharmaceutical compositions
ZA952239A ZA952239B (en) 1994-03-22 1995-03-17 Pharmaceutical compositions
NZ500588A NZ500588A (en) 1994-03-22 1995-03-17 Oil in water emulsions containing propofol and edetate for producing anaesthesia
DE19509828A DE19509828A1 (de) 1994-03-22 1995-03-17 Pharmazeutische Zusammensetzungen
CH01282/04A CH694423A5 (de) 1994-03-22 1995-03-17 Verwendung von Edetat zur Stabilisierung von pharmzeutischen Zusammensetzungen.
BE9500241A BE1009198A5 (fr) 1994-03-22 1995-03-17 Compositions pharmaceutiques nouvelles contenant du propofol.
PCT/GB1995/000579 WO1996029064A1 (en) 1994-03-22 1995-03-17 Oil in water emulsions containing propofol and edetate
NZ282005A NZ282005A (en) 1994-03-22 1995-03-17 Oil in water emulsions containing propofol (2,6 diisopropylphenol) and edetate
PL95322278A PL186354B1 (pl) 1994-03-22 1995-03-17 Jałowe kompozycje farmaceutyczne oraz sposoby ograniczania potencjału wzrostowego drobnoustrojów i poprawiania czasu stosowania emulsji
HU9702180A HU227951B1 (en) 1994-03-22 1995-03-17 Oil in water emulsions containing propofol and disodium edetate
CH00393/03A CH693762A5 (de) 1994-03-22 1995-03-17 Wässrige Zusammensetzungen enthaltend eine Öl-in-Wasser-Emulsion
CH02011/97A CH693764A5 (de) 1994-03-22 1995-03-17 Pharmazeutische Zusammensetzung enthaltend Propofol und Edetat.
FR9503128A FR2731617B1 (fr) 1994-03-22 1995-03-17 Compositions pharmaceutiques nouvelles contenant du propofol
EP95911412A EP0814787B1 (en) 1994-03-22 1995-03-17 Oil in water emulsions containing propofol and disodium edetate
BR9510452A BR9510452A (pt) 1994-03-22 1995-03-17 Composição farmacêutica e aquosa estéril para a administração parenteral processos para limitar o potencial de crescimento microbiano em composição farmacêutica estéril para a administração parenteral para produzir anestesia em um animal de sangue quente e para aperfeiçoar o tempo de administração e/ou o tempo entre as trocas de conjuntos
CA002212794A CA2212794C (en) 1994-03-22 1995-03-17 Oil in water emulsions containing propofol and edetate
NO19974278A NO320007B1 (no) 1994-03-22 1997-09-16 Steril farmasoytisk blanding inneholdende propofol og edetat for parenteral administrering, fremgangsmate for a begrense potensialet for mikrobevekst i blandingen, samt anvendelse derav.
JP00624199A JP4012328B2 (ja) 1994-03-22 1999-01-13 エデテートを含有する水中油滴エマルジョン
FI20085586A FI120641B (fi) 1994-03-22 2008-06-13 Ruuansulatuskanavan ulkopuolisesti annettavat rasvaemulsiot, jotka sisältävät edetaattia säilöntäaineena

Publications (3)

Publication Number Publication Date
ITMI950529A0 true ITMI950529A0 (it) 1995-03-17
ITMI950529A1 ITMI950529A1 (it) 1996-09-17
IT1281193B1 IT1281193B1 (it) 1998-02-17

Family

ID=48793621

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI000529A IT1281193B1 (it) 1994-03-22 1995-03-17 Composizioni farmaceutiche contenenti 2,6 diisopropilfenolo (propofol) e metodo per la loro preparazione

Country Status (33)

Country Link
US (1) US5714520A (it)
EP (2) EP0814787B1 (it)
JP (2) JP3067806B2 (it)
AT (2) ATE312625T1 (it)
AU (1) AU710143B2 (it)
BE (1) BE1009198A5 (it)
BR (1) BR9510452A (it)
CA (1) CA2212794C (it)
CH (4) CH693762A5 (it)
CZ (1) CZ297549B6 (it)
DE (2) DE19509828A1 (it)
DK (3) DK0814787T3 (it)
ES (2) ES2183869T3 (it)
FI (2) FI120640B (it)
FR (1) FR2731617B1 (it)
GB (2) GB9405593D0 (it)
HK (1) HK1008927A1 (it)
HU (1) HU227951B1 (it)
IL (1) IL113021A (it)
IT (1) IT1281193B1 (it)
LU (1) LU90136B1 (it)
MX (1) MX9707005A (it)
NO (2) NO320007B1 (it)
NZ (2) NZ282005A (it)
PL (1) PL186354B1 (it)
PT (1) PT814787E (it)
RU (1) RU2147432C1 (it)
SE (2) SE523909C2 (it)
SI (1) SI0814787T1 (it)
SK (1) SK286375B6 (it)
TW (1) TW458781B (it)
WO (1) WO1996029064A1 (it)
ZA (1) ZA952239B (it)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
MY113046A (en) * 1994-03-22 2001-11-30 Astrazeneca Uk Ltd Pharmaceutical compositions
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
KR19980025601A (ko) * 1996-10-04 1998-07-15 우동일 혈관주사제용 프로포폴 유탁액의 제조방법
CH692322A5 (it) 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
DE19757224A1 (de) 1997-12-22 1999-07-01 Bayer Ag Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation
AU750040B2 (en) 1998-02-10 2002-07-11 Sicor Inc. Propofol composition containing sulfite
US6254853B1 (en) 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
KR100777647B1 (ko) * 1998-08-19 2007-11-19 스키에파마 캐나다 인코포레이티드 프로포폴의 수용성 주사용 분산액
US6150423A (en) 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6140373A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
ES2232195T3 (es) * 1999-01-28 2005-05-16 Dinesh Shantilal Patel Solucion parenteral de propofol (2,6-diisopropilfenol) y 2,5-di-o-metil-1,4;3,6-dianhidro-d-glucitol como solvente.
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
EP1202719B1 (en) * 1999-06-21 2006-05-31 Kuhnil Pharmaceutical Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
SE0001865D0 (sv) * 2000-05-19 2000-05-19 Astrazeneca Ab Management of septic shock
GB0012597D0 (en) * 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
CN1217657C (zh) * 2000-05-25 2005-09-07 阿斯特拉曾尼卡有限公司 存活效益
EP1292282A2 (en) 2000-06-16 2003-03-19 RTP Pharma Inc. Improved injectable dispersions of propofol
IN188917B (it) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
KR100921199B1 (ko) 2001-05-11 2009-10-13 미쓰비시 타나베 파마 코퍼레이션 안정하고 고농도인 피라졸론 유도체를 포함하는 주사제
JP4127757B2 (ja) * 2001-08-21 2008-07-30 株式会社エヌ・ティ・ティ・ドコモ 無線通信システム、通信端末装置、及びバースト信号送信方法
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
US8541472B2 (en) 2001-12-05 2013-09-24 Aseptica, Inc. Antiseptic compositions, methods and systems
BRPI0307017B1 (pt) 2002-01-25 2015-11-10 Theravance Biopharma R & D Ip Llc compostos de éster de ácido fenilacético, composições farmacêuticas e uso de ditos compostos para preparar um medicamento útil para induzir ou manter a anestesia ou sedação
AU2003230691A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
BR0308857A (pt) * 2002-04-08 2005-01-04 Guilford Pharm Inc Composições farmacêuticas contendo promedicamentos de propofol, solúveis em água, e métodos de administrar os mesmos
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
KR101145692B1 (ko) 2002-07-29 2012-05-25 트렌스폼 파마수티컬스 인코퍼레이티드 수성 2,6-디이소프로필페놀 약제학적 조성물
EP1555976A4 (en) * 2002-10-29 2007-11-14 Transform Pharmaceuticals Inc PROPOFOL ASSOCIATED WITH CYSTEINE
LT1585548T (lt) 2002-12-09 2018-09-25 Abraxis Bioscience, Llc Farmakologinių agentų kompozicijos ir įvedimo būdai
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
PT1648413E (pt) * 2003-07-23 2009-12-28 Theravance Inc Composições farmacêuticas de um agente hipnótico sedativo de acção curta
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
EP1680409A4 (en) * 2003-10-24 2007-12-05 Auspex Pharmaceuticals Inc PH-SENSITIVE 2,6-DIISOPROPYLPHENOL PROMEDICAMENTS
CA2556185C (en) 2004-02-13 2010-09-21 Bioavailability, Inc. A microemulsion preparation of high concentration propofol for anesthetic uses
EP1799266A2 (en) * 2004-09-13 2007-06-27 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2007000662A2 (en) * 2005-02-03 2007-01-04 Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
WO2006089120A2 (en) 2005-02-18 2006-08-24 Abraxis Bioscience, Inc Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
WO2006128088A1 (en) * 2005-05-27 2006-11-30 Sandhya Goyal Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
JP2009503059A (ja) 2005-08-05 2009-01-29 ブハラット セルムズ アンド ヴァクシンズ リミテッド 防腐効果を有する静脈プロポフォールエマルジョン組成物
AU2006310044A1 (en) * 2005-08-12 2007-05-10 Bharat Serums & Vaccines Ltd. Aqueous anaesthetic compositions comprising propofol
WO2007022437A2 (en) * 2005-08-18 2007-02-22 Auspex Pharmaceuticals, Inc. Therapeutic agents for the treatment of cancer and metabolic disorders
DK3311805T3 (da) * 2005-08-31 2020-04-14 Abraxis Bioscience Llc Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
WO2007027941A2 (en) * 2005-08-31 2007-03-08 Abraxis Bioscience, Llc. Compositions and methods for preparation of poorly water soluble drugs with increased stability
US7589239B2 (en) * 2005-09-02 2009-09-15 Auspex Pharmaceuticals Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN1903187B (zh) * 2006-03-21 2012-05-30 沈阳药科大学 含有局麻药的复方异丙酚注射剂及制备工艺
CA2685813A1 (en) * 2007-05-09 2008-11-20 Pharmacofore, Inc. Therapeutic compounds
PL2301908T3 (pl) 2007-05-09 2015-02-27 Sowood Healthcare Llc (-)-stereoizomer 2,6-di-sec-butylofenolu i jego analogi do propagowania działania przeciwwymiotnego, leczenia nudności i wymiotów oraz do leczenia migreny
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
PT2320740E (pt) 2008-08-01 2014-06-12 Hospira Inc Composições farmacêuticas de clevidipine e métodos para produzir concentrações pobres em impurezas das mesmas
WO2010082092A1 (en) 2009-01-13 2010-07-22 Claris Lifesciences Limited Propofol based anesthetic with preservative
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
AU2011313852B2 (en) * 2010-10-12 2015-07-02 Chiesi Farmaceutici S.P.A. Clevidipine emulsion formulations containing antimicrobial agents
CN102407986B (zh) * 2011-11-03 2013-11-27 南通四方冷链装备股份有限公司 隔料装置
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
CN102579555A (zh) * 2012-03-01 2012-07-18 四川大学华西医院 注射用脂肪乳在作为拮抗全身麻醉用药作用的药物制备中的应用
MX2014013826A (es) 2012-05-16 2018-04-24 Singh Mewa Composiciones farmaceuticas para la entrega de farmacos sustancialmente solubles en agua.
WO2017031261A1 (en) 2015-08-20 2017-02-23 Mewa Singh Polyphenolic polymer to make water-insoluble molecules become water-soluble
US11357743B2 (en) 2017-04-19 2022-06-14 Mayo Foundation For Medical Education And Research Ketamine and propofol admixture

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384545A (en) * 1965-03-09 1968-05-21 Hoffmann La Roche Injectable aqueous emulsions of fat soluble vitamins
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
JPS5916818A (ja) * 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
SE8505047L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Fettemulsion
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
JPH075456B2 (ja) * 1988-10-01 1995-01-25 参天製薬株式会社 点眼液
WO1990006055A1 (en) * 1988-11-29 1990-06-14 Unilever Plc Antimicrobial agents and uses thereof
GB8828517D0 (en) * 1988-12-07 1989-01-11 Leopold & Co Ag Stable emulsions
US5079003A (en) * 1990-03-14 1992-01-07 Adelia Scaffidi Skin lotions and creams
JP3308555B2 (ja) * 1991-03-08 2002-07-29 カネボウ株式会社 微細化エマルション組成物の製造方法
JP2811036B2 (ja) * 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンｅ点眼剤
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
FI973702A0 (fi) 1997-09-16
BE1009198A5 (fr) 1996-12-03
NZ282005A (en) 2000-01-28
JP4012328B2 (ja) 2007-11-21
US5714520A (en) 1998-02-03
JPH11500737A (ja) 1999-01-19
CA2212794A1 (en) 1996-09-26
AU1898895A (en) 1996-10-08
DE69528714T2 (de) 2003-06-12
FI20085586A (fi) 2008-06-13
IT1281193B1 (it) 1998-02-17
SE9703274L (sv) 1997-09-10
FI120640B (fi) 2010-01-15
JP3067806B2 (ja) 2000-07-24
HUT77358A (hu) 1998-03-30
DE19509828A1 (de) 1996-09-19
EP1238677B1 (en) 2005-12-14
SE9703274D0 (sv) 1997-09-10
CA2212794C (en) 2000-09-12
NO974278L (no) 1997-09-16
BR9510452A (pt) 1998-05-19
ITMI950529A1 (it) 1996-09-17
RU2147432C1 (ru) 2000-04-20
ATE312625T1 (de) 2005-12-15
FR2731617B1 (fr) 1997-05-30
GB9505405D0 (en) 1995-05-03
ZA952239B (en) 1996-09-17
CZ290497A3 (en) 1997-12-17
FI120641B (fi) 2010-01-15
CZ297549B6 (cs) 2007-02-07
SE0400115L (sv) 2004-01-21
CH693762A5 (de) 2004-01-30
SE523909C2 (sv) 2004-06-01
NO320007B1 (no) 2005-10-10
SI0814787T1 (en) 2003-04-30
EP1238677A2 (en) 2002-09-11
GB2298789A (en) 1996-09-18
EP1238677A3 (en) 2003-01-22
IL113021A (en) 2001-04-30
GB9405593D0 (en) 1994-05-11
DK1238677T3 (da) 2006-03-06
ATE226817T1 (de) 2002-11-15
NO20041838L (no) 1997-09-16
FR2731617A1 (fr) 1996-09-20
TW458781B (en) 2001-10-11
WO1996029064A1 (en) 1996-09-26
DE69528714D1 (de) 2002-12-05
PL322278A1 (en) 1998-01-19
NZ500588A (en) 2001-04-27
EP0814787A1 (en) 1998-01-07
PT814787E (pt) 2003-02-28
CH694396A5 (de) 2004-12-31
HU227951B1 (en) 2012-07-30
DK0814787T3 (da) 2003-01-06
CH693764A5 (de) 2004-01-30
PL186354B1 (pl) 2003-12-31
ES2183869T3 (es) 2003-04-01
CH694423A5 (de) 2005-01-14
MX9707005A (es) 1997-11-29
GB2298789B (en) 1999-12-08
FI973702A (fi) 1997-09-16
ES2253469T3 (es) 2006-06-01
HK1008927A1 (en) 1999-07-16
AU710143B2 (en) 1999-09-16
JPH11263725A (ja) 1999-09-28
NO974278D0 (no) 1997-09-16
EP0814787B1 (en) 2002-10-30
SE0400115D0 (sv) 2004-01-21
NO334956B1 (no) 2014-08-04
SK124797A3 (en) 1998-01-14
SK286375B6 (sk) 2008-08-05
SE527123C2 (sv) 2005-12-27
DK106697A (da) 1997-09-17
IL113021A0 (en) 1995-12-08
LU90136B1 (de) 1997-11-27

Similar Documents

Publication Publication Date Title
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
IL114492A0 (en) Benzimidazole derivatives their preparation and pharmaceutical compositions containing them
ID18352A (id) Komposisi-komposisi farmasi
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
IL117397A (en) Substituted naphthyl compounds and pharmaceutical compositions comprising them
BR9509688A (pt) Composto e composição farmacêutica
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
BR9507768A (pt) Composição farmacêutica
FI960316A (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI973229A (fi) Uusi farmaseuttinen koostumus
ITMI941169A0 (it) Formulazioni farmaceutiche
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
PT941100E (pt) Composicoes farmaceuticas
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI951155A0 (fi) Farmaseuttinen valmiste
IL119603A0 (en) Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
EE9500029A (et) Farmatseutiline pihustatav kompositsioon ja selle saamise meetod
FI962738A0 (fi) Farmaseuttiset koostumukset
ITMI950880A0 (it) Composti eterociclici composizioni farmaceutiche che li comprendono e procedimento per la loro preparazione

Legal Events

Date Code Title Description
0001 Granted